Diagnostyka S.A.

DIA · WAR · Healthcare / Diagnostics & Research

156.00PLN+2.00 (+1.30%)

Price History

Full chart

Market Stats

Previous Close154.00

Open154.90

Day Range153.60 – 156.50

52-Week Range142.78 – 202.86

Volume33.26K

Market Cap5.37B

P/E (TTM)21.06

Forward P/E0.00

EPS7.55

Dividend Yield2.77%

50-Day Avg165.79

200-Day Avg171.92

About

Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers specialized research in the field of microbiology, autoimmunity, toxicology, and molecular biology, as well as human genome research, histopathological examinations, immunohistochemical tests, cytological tests, and cytogenetic tests. The company provides services to individual clients, and public and private entities. Diagnostyka S.A. was founded in 1998 and is headquartered in Kraków, Poland.

Company Details

SectorHealthcare
IndustryDiagnostics & Research
CEOMr. Jakub Swadzba
Employees8.64K
HeadquartersUl. Prof. Michala Zyczkowskiego 16, Kraków, Poland, 31-864, Poland
Websitehttps://www.diag.pl

Leadership

Mr. Jakub SwadzbaCo-Founder, CEO & President of the Management Board
Mr. Jaromir PelczarskiVice-President of the Management Board & Chief Transformation Officer
Ms. Marta Rogalska-KupiecVice-President of the Management Board & Chief Operating Officer
Mr. Dariusz ZowczakChief Sales Officer & Vice-President of the Management Board

Financials

Income Statement

Currency: PLN	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.84B	1.44B	1.59B	1.95B	2.41B
Growth (%)	-	-22.10%	+10.62%	+22.81%	+23.60%
Cost of Revenue	538.12M	500.04M	554.52M	420.00M	505.03M
Gross Profit	1.30B	935.54M	1.03B	1.53B	1.91B
Gross Margin	70.80%	65.17%	65.08%	78.46%	79.05%
Operating Expense	617.15M	683.50M	800.03M	1.19B	1.52B
Operating Income	687.51M	252.04M	233.43M	337.26M	383.66M
Operating Margin	37.31%	17.56%	14.70%	17.29%	15.92%
EBITDA	-	380.52M	375.06M	510.09M	587.54M
EBITDA Margin	-	26.51%	23.62%	26.16%	24.37%
Net Income	557.79M	167.41M	123.43M	223.33M	251.60M
Net Income Margin	30.27%	11.66%	7.77%	11.45%	10.44%
Interest Expense	23.30M	32.81M	54.20M	57.37M	68.86M
Interest Expense % of Total Revenue	1.26%	2.29%	3.41%	2.94%	2.86%

Balance Sheet

Currency: PLN	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.26B	1.20B	1.40B	1.72B	2.07B
Total Liabilities	819.33M	878.40M	1.06B	1.28B	1.52B
Total Equity	437.58M	312.53M	325.13M	418.63M	528.40M
Cash	164.48M	90.97M	94.85M	40.51M	18.42M
Net Debt	111.58M	335.57M	440.24M	550.55M	615.38M

Cash Flow

Currency: PLN	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	738.52M	283.88M	335.97M	415.43M	551.77M
Capital Expenditure	131.58M	89.37M	81.31M	132.71M	204.78M
Free Cash Flow	606.94M	194.52M	254.66M	282.72M	346.99M
Dividends Paid	413.37M	294.34M	112.07M	105.66M	111.73M
FCF to OCF	82.18%	68.52%	75.80%	68.05%	62.89%
Dividend Paid to FCF	68.11%	151.32%	44.01%	37.37%	32.20%

Earnings

Report Date	Mar 31, 2025	Sep 18, 2025	Nov 20, 2025	May 29, 2026	Sep 10, 2026	Nov 26, 2026
EPS Estimate	-	-	-	-	-	-
EPS Actual	2.16	1.89	2.31	2.45	1.70	-
Surprise	-	-	-	-	-	-
Timing	-	-	-	-	After-hours	Pre-market

Key Statistics & Ratios

Market Cap5.37B

Enterprise Value6.77B

Trailing P/E21.06

Forward P/E0.00

Price / Sales2.08

Price / Book10.92

EPS7.55

Book Value15.11

Revenue (TTM)2.58B

Gross Profit (TTM)2.03B

EBITDA606.27M

Profit Margin9.86%

Operating Margin13.92%

Return on Equity55.37%

Return on Assets11.77%

Shares Outstanding33.76M

Shares Float16.40M

Dividend Yield2.77%

Dividend Rate4.40

Payout Ratio68.13%

Dividends

20261×

4.40Jun 1, 2026

20251×

3.31Jun 3, 2025